Deciphera Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DCPH and other ETFs, options, and stocks.

About DCPH

Deciphera Pharmaceuticals, Inc. engages in discovering, developing, and delivering important new medicines to patients for the treatment of cancer. The firm designs a drug candidate, DCC-2618, to inhibit the full spectrum of mutant or amplified KIT and PDGFRa kinases that drive cancers such as gastrointestinal stromal tumors (GIST), advanced systemic mastocytosis (ASM), gliomas, and other solid tumors. 

CEO
Steven L. Hoerter
CEOSteven L. Hoerter
Employees
280
Employees280
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2003
Founded2003
Employees
280
Employees280

DCPH Key Statistics

Market cap
1.26B
Market cap1.26B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
880.75K
Average volume880.75K
High today
$19.31
High today$19.31
Low today
$17.43
Low today$17.43
Open price
$17.43
Open price$17.43
Volume
299.63K
Volume299.63K
52 Week high
$37.99
52 Week high$37.99
52 Week low
$6.51
52 Week low$6.51

Analyst ratings

45%

of 11 ratings
Buy
45.5%
Hold
36.4%
Sell
18.2%

DCPH Earnings

-$1.51
-$1.01
-$0.50
-$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 1, Pre-Market
ActualExpected Nov 1, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.